MILNE GEORGE M JR
SEC Form 4 insider trading activity
MILNE GEORGE M JR has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, MILNE GEORGE M JR is listed as Director at Amylyx Pharmaceuticals, Inc. Inside the rolling window, MILNE GEORGE M JR reported no open-market purchases and 1 open-market sale totaling $831K in AMLX.
Companies traded
Other insiders at AMLX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$831K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MILNE GEORGE M JR made?
MILNE GEORGE M JR has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does MILNE GEORGE M JR trade?
MILNE GEORGE M JR has filed SEC Form 4 disclosures for 1 company, including AMLX.
When was MILNE GEORGE M JR's most recent SEC Form 4 filing?
MILNE GEORGE M JR's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is MILNE GEORGE M JR's total buy and sell value in the current window?
Inside the rolling retention window, MILNE GEORGE M JR bought $0 and sold $831K based on SEC Form 4 filings.
What was MILNE GEORGE M JR's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 AMLX shares on 2026-10-05, worth $831K, per SEC Form 4 filings.